Pearl Freier (@pearlf) 's Twitter Profile
Pearl Freier

@pearlf

Founder of Cambridge BioPartners, Inc.

ID: 26368450

calendar_today25-03-2009 00:13:09

41,41K Tweet

9,9K Takipçi

5,5K Takip Edilen

Pearl Freier (@pearlf) 's Twitter Profile Photo
Pearl Freier
@pearlf

7 months ago

Biotech analysts studied 229 preclinical asset deals signed between '10–'15 to see which ones reached late stage clinical development & resulted in revenue for licensors h/t Recon Strategy. Assets without a specified target rarely progressed into the clinic which suggests these

Biotech analysts studied 229 preclinical asset deals signed between '10–'15 to see which ones reached late stage clinical development &amp; resulted in revenue for licensors h/t <a href="/ReconStrategy/">Recon Strategy</a>. Assets without a specified target rarely progressed into the clinic which suggests these